piracetam has been researched along with glutamic acid in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Abramets, II; Komissarov, IV; Samoĭlovich, IM | 1 |
| Zhang, LH; Zhang, SS | 1 |
| Angelopoulos, E; Karayanidis, F; Koutsoukos, E; Maillis, A; Stefanis, C | 1 |
| Brodie, MJ; Forrest, G; Fraser, CM; Leach, JP; Patsalos, PN; Sills, GJ | 1 |
| Alperovich, DV; Lysenko, AV; Mendzheritsky, AM; Uskova, NI | 1 |
| Andreeva, NA; Gudasheva, TA; Isaev, NK; Ostrovskaya, RU; Stel'mashuk, EV; Viktorov, IV | 1 |
| Aldenkamp, AP; Bootsma, HP; Kessels, AG; Leenen, LA; Leonard, BE; Majoie, HJ; Roberts, GM | 1 |
| Hlinák, Z; Krejcí, I | 1 |
| Jensen, JE; Kaufman, RE; Pollack, MH; Renshaw, PF; Simon, NM | 1 |
| Kaminski, RM; Klitgaard, H; Matagne, A; Patsalos, PN | 1 |
| Chen, CC; Lee, CY; Liou, HH | 1 |
| Dehmel, T; Kieseier, BC; Köhne, A; Mausberg, AK; Rose, CR; Stettner, M | 1 |
| Biber, B; Björklund, U; Block, L; Hansson, E; Jörneberg, P; Westerlund, A | 1 |
| Lipton, SA; McKercher, SR; Piña-Crespo, JC; Sanz-Blasco, S; Zhang, X | 1 |
| Antipova, TA; Gudasheva, TA; Nikolaev, SV; Ostrovskaya, PU; Seredenin, SB | 1 |
| Antipova, TA; Gudasheva, TA; Koliasnikova, KN; Seredenin, SB | 1 |
| Akinyemi, A; Michel, G; Sanchez-Gonzalez, MA; Sterkel, S | 1 |
| Anastasio, NC; Cunningham, KA; Davis-Reyes, BD; Smith, AE; Xu, J; Zhou, J | 1 |
1 review(s) available for piracetam and glutamic acid
| Article | Year |
|---|---|
Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
Topics: Animals; Anticonvulsants; Brain; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Epilepsy; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Levetiracetam; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam | 2009 |
2 trial(s) available for piracetam and glutamic acid
| Article | Year |
|---|---|
Ketter's hypothesis of the mood effects of antiepileptic drugs coupled to the mechanism of action of topiramate and levetiracetam.
Topics: Adult; Anticonvulsants; Chi-Square Distribution; Demography; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Fructose; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Levetiracetam; Male; Middle Aged; Models, Biological; Mood Disorders; Odds Ratio; Piracetam; Time Factors; Topiramate | 2005 |
High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Levetiracetam; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nootropic Agents; Piracetam | 2008 |
15 other study(ies) available for piracetam and glutamic acid
| Article | Year |
|---|---|
[The aspartate/NMDA-sensitizing effect of piracetam].
Topics: Allosteric Site; Animals; Aspartic Acid; Electric Conductivity; Glutamates; Glutamic Acid; Membrane Potentials; Microelectrodes; Motor Neurons; Piracetam; Rana esculenta; Receptors, N-Methyl-D-Aspartate | 1991 |
[Relationship between facilitatory effect of piracetam on memory and glutamate receptors].
Topics: Animals; Brain; Discrimination Learning; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Ketamine; Male; Memory; Mice; Piracetam; Receptors, Glutamate; Receptors, Neurotransmitter | 1991 |
Effects of piracetam on single central neurons.
Topics: Acetylcholine; Animals; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Hippocampus; Piracetam; Pyrrolidinones; Rats; Somatosensory Cortex; Synapses; Synaptic Transmission | 1988 |
Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain.
Topics: 4-Aminobutyrate Transaminase; Animals; Anticonvulsants; Brain; Drug Administration Schedule; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamic Acid; Glutamine; Levetiracetam; Male; Mice; Mice, Inbred ICR; Piracetam | 1997 |
Metabolic features of the adaptive effect of delta-sleep inducing peptide and piracetam under hyperoxic conditions.
Topics: Adaptation, Physiological; Animals; Aspartic Acid; Cerebral Cortex; Delta Sleep-Inducing Peptide; gamma-Aminobutyric Acid; Glutamic Acid; Hyperoxia; Male; Mitochondria; Myelin Sheath; Oxygen; Piracetam; Rats; Synaptosomes | 1999 |
Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress.
Topics: 2-Amino-5-phosphonovalerate; Animals; Brain Ischemia; Cells, Cultured; Cerebellum; Dipeptides; Glucose; Glutamic Acid; Neurons; Neuroprotective Agents; Nootropic Agents; Oxidative Stress; Oxygen; Piracetam; Rats; Rats, Wistar | 2000 |
Spontaneous alternation behaviour in rats: kynurenic acid attenuated deficits induced by MK-801.
Topics: Animals; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Exploratory Behavior; Glutamic Acid; Kynurenic Acid; Male; Motor Activity; Nootropic Agents; Piracetam; Rats; Rats, Wistar | 2006 |
Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus.
Topics: Animals; Anticonvulsants; Calcium Channels, P-Type; Calcium Channels, Q-Type; Dentate Gyrus; Excitatory Postsynaptic Potentials; Glutamic Acid; In Vitro Techniques; Levetiracetam; Male; Patch-Clamp Techniques; Piracetam; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2009 |
Levetiracetam exhibits protective properties on rat Schwann cells in vitro.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blotting, Western; Cells, Cultured; Glutamic Acid; In Vitro Techniques; Levetiracetam; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neuroprotective Agents; Oxidative Stress; Piracetam; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Schwann Cells | 2011 |
A new concept affecting restoration of inflammation-reactive astrocytes.
Topics: Actins; Analgesics, Opioid; Animals; Astrocytes; Calcium Signaling; Capillaries; Coculture Techniques; Cytokines; Cytoskeleton; Endothelial Cells; Glutamic Acid; Inflammation; Interleukin-1beta; Levetiracetam; Lipopolysaccharides; Male; Naloxone; Narcotic Antagonists; Nootropic Agents; Oligopeptides; Piracetam; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase | 2013 |
Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes.
Topics: Amyloid beta-Peptides; Astrocytes; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Glutamic Acid; HEK293 Cells; Humans; Levetiracetam; Luminescent Proteins; Microscopy, Fluorescence; Nootropic Agents; Peptide Fragments; Piracetam; Transfection | 2016 |
Dipeptide Piracetam Analogue Noopept Improves Viability of Hippocampal HT-22 Neurons in the Glutamate Toxicity Model.
Topics: Animals; Cell Line; Cell Survival; Dipeptides; Glutamic Acid; Mice; Neurons; Neuroprotective Agents; Piracetam | 2016 |
Neuropeptide cycloprolylglycine increases the levels of brain-derived neurotrophic factor in neuronal cells.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cell Line; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glutamic Acid; Hippocampus; Humans; Mice; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Peptides, Cyclic; Piracetam | 2016 |
Preserving brain function in a comatose patient with septic hyperpyrexia (41.6 °C): a case report.
Topics: Adult; Amantadine; Anticonvulsants; Brain; Brain Injuries; Cognition Disorders; Coma; Dopamine Agents; Drug Therapy, Combination; Glutamic Acid; Humans; Levetiracetam; Male; Malignant Hyperthermia; Piracetam; Tomography, X-Ray Computed | 2017 |
Subanesthetic ketamine with an AMPAkine attenuates motor impulsivity in rats.
Topics: Animals; Antidepressive Agents; Cognition; Dose-Response Relationship, Drug; Glutamic Acid; Impulsive Behavior; Ketamine; Mental Disorders; Neuronal Plasticity; Nootropic Agents; Piracetam; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2021 |